American Thyroid Association
ATA/AACE update treatment of hypothyroidism in adults
Presenters focus on status, effects of iodine intake
Alternative therapies for thyroid disease examined
Off-label TKIs show promise for refractory thyroid cancer
Cabozantinib prolonged PFS in patients with MTC
Targeted next generation sequencing platform detected multiple mutations
QUEBEC CITY — Using targeted next generation sequencing via the AmpliSeq cancer panel on Ion Torrent platform, researchers at the University of Pittsburgh were able to test for 740 mutations across a broad spectrum of human cancer genes. According to researchers, this finding could improve sensitivity of the molecular diagnosis in thyroid surgical and fine needle aspiration samples.
ATA CONFERENCE BLOG: Considering careers, novel drugs, microcarcinoma and basic science
QUEBEC CITY — In today’s blog post, several fellows summarize and discuss some of Friday’s most exciting sessions, including the Lewis E. Braverman Award Lecture on thyroid hormone analogues; the Early Riser Symposium about management of thyroid microcarcinoma; a Fellows’ Track session focused on finding careers in academia; a Basic Science Symposium about thyroid hormone and the brain; and more.
Subclinical hyperthyroidism unrelated to overall, CV mortality
New approaches to thyroidectomy prompt discussion
Experts debate benefits of routine nerve monitoring in thyroid surgery
QUEBEC CITY — Although many clinicians use intraoperative nerve monitoring during thyroid surgery, data do not necessarily associate the practice with improved outcomes. The question of whether it should be used routinely was up for discussion at the American Thyroid Association 82nd Annual Meeting.